The U.S. FDA has expanded the indication of AstraZeneca's Farxiga (dapagliflozin) to treat type 2 diabetes in children as young as 10 years old. The drug was already approved for this indication ...

Farxiga (dapagliflozin) and Jardiance (empagliflozin) are prescription medications that are commonly used for type 2 diabetes ...

GLP-1 receptor agonists and SGLT2 inhibitors were both initially approved for type 2 diabetes. But over the last several ...

AstraZeneca continues to make the case for its Farxiga diabetes drug, highlighting a cardiology analysis that it hopes will convince more doctors to prescribe it in a highly competitive market.

AstraZeneca’s Farxiga has become the latest type 2 diabetes drug to show it can reduce cardiovascular risk in a clinical trial. Boehringer Ingelheim and Eli Lilly’s Jardiance (empagliflozin ...

The medicine, which Novo sells as Rybelsus, cut the risk of cardiovascular complications by 14% when added to standard ...

Lexicon's Inpefa faces fierce competition from established SGLT2 inhibitors, like Farxiga and Jardiance. Read why LXRX stock ...

A Maryland drug affordability board can move forward with a plan to cap how much the state and local governments pay for ...

Medications in this class are all brand names, including empagliflozin (Jardiance), dapagliflozin (Farxiga), canagliflozin (Invokana), and ertugliflozin (Steglatro). Type 2 diabetes is a complex ...

S.S. ANSWER: Empagliflozin (Jardiance) and dapagliflozin (Farxiga) are both medicines for diabetes in the SGLT2 inhibitor class. These work by causing the kidneys to release sugar from the blood ...

After Viatris’ CEO earlier this year promised to be “opportunistic” about future business development moves, the company is ...

S.S. ANSWER: Empagliflozin (Jardiance) and dapagliflozin (Farxiga) are both medicines for diabetes in the SGLT2 inhibitor class. These work by causing the kidneys to release sugar from the blood ...